About Us: Difference between revisions
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Goals''' | '''Goals''' | ||
* Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content. | *Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content. | ||
* Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable. | *Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable. | ||
* Engage community experts and their trainees in curating, updating and utilizing content. | *Engage community experts and their trainees in curating, updating and utilizing content. | ||
* Include cancer variant knowledge identified through diverse methods and across multiple disciplines. | *Include cancer variant knowledge identified through diverse methods and across multiple disciplines. | ||
* Facilitate building educational content that describes the latest advancements in the field. | *Facilitate building educational content that describes the latest advancements in the field. | ||
| Line 25: | Line 25: | ||
'''Leadership''' | '''Leadership''' | ||
Meet our | Meet our <u>[[Leadership|Editorial Leadership]]</u>, <u>[[CCGA Workgroup|CCGA Workgroup Members]]</u> and [[Communications Liaison|<u>Communications Liaison</u>]]. | ||
<br /> | <br /> | ||
Revision as of 16:20, 11 May 2021
Mission
The CCGA is a global collaborative effort to describe clinical context-based knowledge for gene- and chromosome-level abnormalities observed in cancer.
Goals
- Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
- Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
- Engage community experts and their trainees in curating, updating and utilizing content.
- Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
- Facilitate building educational content that describes the latest advancements in the field.
Vision
The global hub for clinical cancer genomic aberrations.
Support
The CCGA is a Cancer Genomics Consortium (CGC)-supported resource.
Leadership
Meet our Editorial Leadership, CCGA Workgroup Members and Communications Liaison.